Diminished quality of life in patients with cancer correlates with tryptophan degradation.
about
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an updateThe indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cellsAn indicator of cancer: downregulation of monoamine oxidase-A in multiple organs and species.CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depressionPotential role of tryptophan and chloride in the inhibition of human myeloperoxidase.Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown.The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.Utility of kynurenic acid for non-invasive detection of metastatic spread to lymph nodes in non-small cell lung cancerAssociation of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis CAccumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.A systematic review of the association between immunogenomic markers and cancer-related fatigueEffects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis.Mechanistic perspective on the relationship between pyridoxal 5'-phosphate and inflammation.Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue.Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium.Polymorphisms of the TRPV2 and TRPV3 genes associated with fibromyalgia in a Korean population.Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke.
P2860
Q28654636-82064B0C-6A8D-4101-A23D-0065A4C9A768Q28744405-13DC5D82-C531-4FFD-82FA-EF58411D4E11Q33325705-E569D767-25A8-4008-80FC-A7EEB8B6CAE1Q33751166-553FA771-6F68-485B-BAFA-CB31E41B8FB5Q33818264-FDD2AF6B-FA07-4522-B32B-AB1B56EC7012Q34277561-6278D2C6-13ED-4AE9-814D-4C5C3759BB15Q34812071-F3FE79EA-0EE5-4412-AD89-90530EE1E661Q34942871-BFA430EE-03C8-40F7-AE28-8C200549E254Q35231633-D336C42F-DC73-4AE1-8CF2-01F4951EACC3Q35604318-29688FE3-C071-405E-B92B-FCE23A585B73Q36098741-3F67680A-1369-4B22-A5BB-970B7DD15C5AQ36245404-50F01635-ACFD-4635-BA13-19A76300DBEAQ38095525-575D8449-71A9-438E-967B-667CBBC985C6Q38366476-AC6BA4AC-F862-45C7-8970-ACFAAB31791BQ38579710-EEBBD71D-A4D4-44B6-AF8D-22B84CDEFD53Q40800045-52636809-DE8F-4A38-AC10-B2C743F6C23EQ48327620-9F823B85-2A1F-402A-A647-5F98993EE94F
P2860
Diminished quality of life in patients with cancer correlates with tryptophan degradation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Diminished quality of life in ...... s with tryptophan degradation.
@en
Diminished quality of life in ...... s with tryptophan degradation.
@nl
type
label
Diminished quality of life in ...... s with tryptophan degradation.
@en
Diminished quality of life in ...... s with tryptophan degradation.
@nl
prefLabel
Diminished quality of life in ...... s with tryptophan degradation.
@en
Diminished quality of life in ...... s with tryptophan degradation.
@nl
P2093
P2860
P1476
Diminished quality of life in ...... s with tryptophan degradation.
@en
P2093
Christiana Winkler
Hubert A Denz
Karin Prassl
Michael Fiegl
P2860
P2888
P304
P356
10.1007/S00432-007-0191-3
P577
2007-03-14T00:00:00Z